City of Hope Global Oncology Symposium

Oncogenic Viruses

City of Hope would like to invite you to the Global Oncology Symposium on Oncogenic Viruses. This Symposium will showcase four sessions with a blend of in-person and virtual speakers, ensuring a comprehensive perspective from cancer control in lower-middle-income countries to taking a deep dive into molecular mechanisms and therapies. Each session consists of presentations from our expert panelists, followed by a Q&A.

Agenda  

October 27, 2023

8:30 a.m. to 3:00 p.m. Pacific Daylight Time
3:30 p.m. to 10:00 p.m. Greenwich Mean Time
4:30 p.m. to 11:00 p.m. Central European Time

Check-in and Breakfast | 8:00 a.m. – 8:30 a.m.

Opening Session | 8:30 a.m. – 8:45 a.m.

  • 8:30 a.m. - 8:35 a.m. | Javier Gordon Ogembo, Ph.D., Welcome Remarks
  • 8:35 a.m. - 8:45 a.m. | John Carpten, Ph.D., Opening Address
Javier Gordon Ogembo, Ph.D.
Welcome Remarks

Javier Gordon Ogembo, Ph.D.

Director, Global Oncology Initiative,
Associate Professor, Department of Immuno-Oncology, City of Hope

Opening Address

John Carpten, Ph.D.

Chief Scientific Officer, Irell & Manella Cancer Center. Director's Distinguished Chair, Morgan & Helen Chu Director's Chair of the Beckman Research Institute. Director, Comprehensive Cancer Center. Director, Beckman Research Institute of City of Hope

Session 1 ― 8:50 a.m. - 9:50 a.m.

Session Chair: Narissa Nonzee, Ph.D. & Javier Gordon Ogembo, Ph.D.

  • 8:50 a.m. - 9:15 a.m. | Douglas R. Lowy, M.D. Keynote Address: Controlling Cancer in Low-and-Middle Income Countries: The Example of Cervical Cancer
  • 9:15 a.m. - 9:40 a.m | Satish Gopal, M.D., M.P.H., Alleviating EBV & KSHV-Mediated Suffering in Africa
  • 9:40 a.m. - 9:45 a.m. | Q&A
Session Chair

Narissa Nonzee, Ph.D.

Assistant Professor, Division of Health Equities, Department of Population Sciences, City of Hope

Javier Gordon Ogembo, Ph.D.
Session Chair

Javier Gordon Ogembo, Ph.D.

Director, Global Oncology Initiative, Associate Professor, Department of Immuno-Oncology, City of Hope 

Keynote Address ― Controlling Cancer in Low-and-Middle Income Countries: The Example of Cervical Cancer

Douglas R. Lowy M.D.

Principal Deputy Director, National Cancer Institute (NCI), Head of Signaling and Oncogenesis Section, Chief of Laboratory of Cellular Oncology, NCI Center for Cancer Research, National Institutes of Health, MD, USA

Alleviating EBV & KSHV-mediated suffering in Africa

Satish Gopal, M.D., M.P.H.

Director, Center for Global Health, National Cancer Institute,
National Institutes of Health, MD, USA.

Session 2 | 10:00 a.m. - 11:30 a.m.

Session Chair: Don J. Diamond, Ph.D.

  • 10:00 a.m. - 10:25 a.m. | Christian Münz, PhD., Immune control of oncogenic human gamma-herpesviruses
  • 10:25 a.m. - 10:50 a.m. | Julia Li, PhD., A previously missing link between Epstein Barr Virus and cancer
  • 10:50 a.m. - 11:15 a.m. | Jeffrey Cohen, MD., Use of Vaccines and Monoclonal Antibodies to Prevent Epstein-Barr Virus Infection and Disease
  • 11:15 a.m. - 11:30 a.m. | Q&A
     
Session Chair

Don J. Diamond, Ph.D.

Professor, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope

Immune control of oncogenetic human gamma-herpesviruses

Christian Münz, Ph.D.

Professor, Institute of Experimental Immunology, University of Zurich, Switzerland

A previously missing link between Epstein Barr Virus and cancer

Julia Li, Ph.D.

Damon Runyon Postdoctoral Fellow, Don Cleveland Lab, University of California San Diego, USA.

Use of Vaccines and Monoclonal Antibodies to Prevent Epstein-Barr Virus Infection and Disease

Jeffrey I. Cohen, M.D.

Chief, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA.

Lunch — 11:30 a.m. - 12:10 p.m.

Session 3 | 12:10 p.m. - 1:10 p.m.

Session Chair: Ana I. Tergas, M.D., M.P.H.

  • 12:10 p.m. - 12:35 p.m. | Patricia Gordon, M.D., Community-Based HPV Testing & Treatment Program in Kenya
  • 12:35 p.m. - 1:00 p.m. | Rebecca Lepsik, R.N., B.S., B.A., Community-Based HPV Testing & Treatment Program in Kenya
  • 1:00 p.m. - 1:10 p.m. | Q&A
Session Chair

Ana I. Tergas, M.D.

Assistant Professor,
Department of Surgery, Division of Gynecologic Oncology, Department of Population Sciences, Division of Health Equities, City of Hope

Community-Based HPV Testing & Treatment Program in Kenya

Patricia Gordon, M.D.

Founding Director and Chair of the Board,
CureCervicalCancer Organization, CA, USA

Community-Based HPV Testing & Treatment Program in Kenya

Rebecca Lepsik, R.N., B.S., B.A.

Executive Director, CureCervicalCancer Organization, CA, USA

Session 4 | 1:20 p.m. - 2:20 p.m.

Session Chair: Laleh Melstrom, M.D., M.S.

  • 1:20 p.m. - 1:45 p.m. | Michael J. Sofia, Ph.D., FRSC, Curing Chronic Viral Hepatitis: A Story of Transformational Success and Another of Enduring Hope
  • 1:45 p.m. - 2:10 p.m. | Antonio Bertoletti, M.D., Adoptive T cell therapy against HBV-related Hepatocellular carcinoma
  • 2:10 p.m. - 2:20 p.m. | Q&A 
Session Chair

Laleh Melstrom, M.D., M.S.

Chief, Division of Surgical Oncology, Department of Surgery,
Associate Professor of Surgery and Immuno-Oncology, City of Hope

Curing Chronic Viral Hepatitis: A Story of Transformational Success and Another of Enduring Hope

Michael J. Sofia, Ph.D., FRSC

Chief Scientific Officer & Co-Founder, Arbutus Biopharma, Inc.
PA, USA.

Adoptive T cell therapy against HBV-related Hepatocellular carcinoma

Antonio Bertoletti, M.D.

Professor, Duke-NUS Medical School,
Signature Research Program - Emerging Infectious Diseases, Singapore

Closing remarks | 2:20 p.m. - 2:30 p.m.

Closing Remarks

Stephen Gruber, M.D., Ph.D., M.P.H.

Vice President, City of Hope National Medical Center. Eva and Ming Hsieh Family Director’s Chair of the Center for Precision Medicine. Professor, Division of Molecular Pharmacology, Department of Medical Oncology & Therapeutics Research, City of Hope

Reception — 2:30 - 3:30 p.m.